Filing Details
- Accession Number:
- 0001179110-20-010871
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-06 16:40:47
- Reporting Period:
- 2020-11-04
- Accepted Time:
- 2020-11-06 16:40:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578962 | Walter Stuart Peltz | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-11-04 | 11,037 | $60.00 | 12,178 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Acquisiton | 2020-11-04 | 4,900 | $27.05 | 17,078 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2020-11-04 | 4,900 | $60.00 | 12,178 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Acquisiton | 2020-11-04 | 3,440 | $30.86 | 15,618 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2020-11-04 | 3,440 | $60.00 | 12,178 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Acquisiton | 2020-11-04 | 500 | $12.64 | 12,678 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2020-11-04 | 500 | $60.00 | 12,178 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Acquisiton | 2020-11-04 | 1,575 | $11.23 | 13,753 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2020-11-04 | 1,575 | $60.00 | 12,178 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Acquisiton | 2020-11-04 | 2,505 | $18.01 | 14,683 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2020-11-04 | 2,505 | $60.00 | 12,178 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Acquisiton | 2020-11-04 | 7,560 | $30.86 | 19,738 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2020-11-04 | 7,560 | $60.00 | 12,178 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Acquisiton | 2020-11-04 | 2,362 | $11.23 | 14,540 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2020-11-04 | 2,362 | $60.00 | 12,178 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Acquisiton | 2020-11-04 | 7,065 | $18.01 | 19,243 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2020-11-04 | 7,065 | $60.00 | 12,178 | No | 4 | S | Indirect | By Spouse |
| Common Stock | Acquisiton | 2020-11-04 | 8,421 | $33.02 | 20,599 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2020-11-04 | 8,421 | $60.00 | 12,178 | No | 4 | S | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Spouse |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right To Buy) | Disposition | 2020-11-04 | 4,900 | $27.05 | 4,900 | $27.05 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2020-11-04 | 3,440 | $30.86 | 3,440 | $30.86 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2020-11-04 | 500 | $12.64 | 500 | $12.64 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2020-11-04 | 1,575 | $11.23 | 1,575 | $11.23 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2020-11-04 | 2,505 | $18.01 | 2,505 | $18.01 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-04 | 7,560 | $30.86 | 7,560 | $30.86 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-04 | 2,362 | $11.23 | 2,362 | $11.23 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-04 | 7,065 | $18.01 | 7,065 | $18.01 |
| Common Stock | Stock Option (Right To Buy) | Disposition | 2020-11-04 | 8,421 | $33.02 | 8,421 | $33.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-01-28 | No | 4 | M | Indirect | |
| 7,560 | 2026-01-03 | No | 4 | M | Indirect | |
| 375 | 2026-11-16 | No | 4 | M | Indirect | |
| 4,725 | 2027-01-02 | No | 4 | M | Indirect | |
| 20,464 | 2028-01-02 | No | 4 | M | Indirect | |
| 0 | 2026-01-03 | No | 4 | M | Indirect | |
| 2,363 | 2027-01-02 | No | 4 | M | Indirect | |
| 13,399 | 2028-01-02 | No | 4 | M | Indirect | |
| 18,529 | 2029-01-21 | No | 4 | M | Indirect |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right To Buy) | $490.80 | 2021-04-27 | 58 | 58 | Indirect | |
| Common Stock | Stock Option (Right To Buy) | $218.40 | 2022-01-10 | 38 | 38 | Indirect | |
| Common Stock | Stock Option (Right To Buy) | $51.00 | 2025-01-02 | 10,880 | 10,880 | Indirect | |
| Common Stock | Stock Option (Right to Buy) | $51.16 | 2030-01-28 | 28,600 | 28,600 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2021-04-27 | 58 | 58 | Indirect |
| 2022-01-10 | 38 | 38 | Indirect |
| 2025-01-02 | 10,880 | 10,880 | Indirect |
| 2030-01-28 | 28,600 | 28,600 | Indirect |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person's spouse on May 11, 2020.
- Includes 258 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2020.
- Currently exercisable.
- This option was granted on November 17, 2016 and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.
- This option was granted on January 3, 2017 and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
- This option was granted on January 3, 2018 and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
- This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
- This option was granted on January 29, 2020 and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 29, 2021.
Billionaire Hedge Funds
